FLGTFulgent Genetics, Inc.
$20.87-7.8% 1Y
$20.87
$13.7952 weeks$30.85
Is the price fair?
What FLGT's price assumes
Fulgent Genetics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.41× revenue.
1.41
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.43
Price / book · as of 2026-Q1
- EV / sales
- 1.37
EV / sales
Details›
- Price / bookas of 2026-Q1
- 0.43
- EV / EBIToperating margin −38%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 1.37
- Market capitalisation
- $593M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #14 of 21 by RyuScore